Trials / Conditions / Refractory Histiocytic and Dendritic Cell Neoplasm
Refractory Histiocytic and Dendritic Cell Neoplasm
3 registered clinical trials studyying Refractory Histiocytic and Dendritic Cell Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating NCT04320888 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neop NCT04640779 | Mayo Clinic | Phase 1 |
| Active Not Recruiting | Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders Wi NCT03698994 | National Cancer Institute (NCI) | Phase 2 |